Lack of antigenicity of recombinant human thyrotropin after multiple injections in patients with differentiated thyroid cancer

被引：6

作者：

Paterakis, T ^{[1
]}

Ebels, H

Mallick, UK

Proud, G

Jones, N

Lucraft, H

Fenwick, J

Weightman, D

Kendall-Taylor, P

Perros, P

机构：

[1] Freeman Rd Hosp, NE England Thyroid Canc Grp, Med Unit 3, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England

[2] Genzyme BV, Naarden, Netherlands

来源：

THYROID | 2000年 / 10卷 / 07期

关键词：

D O I：

10.1089/thy.2000.10.623

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：623 / 623

页数：1

共 3 条

[1] A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer [J].

Haugen, BR ;

Pacini, F ;

Reiners, C ;

Schlumberger, M ;

Ladenson, PW ;

Sherman, SI ;

Cooper, DS ;

Graham, KE ;

Braverman, LE ;

Skarulis, MC ;

Davies, TF ;

DeGroot, LJ ;

Mazzaferri, EL ;

Daniels, GH ;

Ross, DS ;

Luster, M ;

Samuels, MH ;

Becker, DV ;

Maxon, HR ;

Cavalieri, RR ;

Spencer, CA ;

McEllin, K ;

Weintraub, BD ;

Ridgway, EC .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :3877-3885

[2]

LANDENSON PW, 1997, NEW ENGL J MED, V337, P888

[3] TREATMENT OF THYROID CANCER METASTASES WITH TSH AND I131 DURING THYROID HORMONE MEDICATION [J].

STURGEON, CT ;

DAVIS, FE ;

CATZ, B ;

PETIT, D ;

STARR, P .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1953, 13 (11) :1391-1407

← 1 →